Position in GNLX
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$30,130
+$5,906 QoQ
Shares Held
10,010
0.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 7 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Plancorp, LLC holds $5,642,142 across 6 Biotechnology names. GNLX ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
396,354 | $3,470,079 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
11,128 | $882,339 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
907 | $565,550 | |
| 4 | EXEL |
Exelixis, Inc.
|
8,068 | $438,979 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
69,500 | $255,065 | |
| 6 | GNLX |
GENELUX Corp
This page
|
10,010 | $30,130 |
All Filings in GNLX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,130 | 10,010 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $24,224 | 10,010 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $43,643 | 10,010 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $42,042 | 10,010 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $28,728 | 10,010 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $27,027 | 10,010 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $23,623 | 10,010 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $43,205 | 18,230 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $35,548 | 18,230 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $117,218 | 18,230 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||